Skip to main content
. 2017 Jan 10;7:40285. doi: 10.1038/srep40285

Figure 2. Immunofluorescence characterization of transdifferentiated iCM (cardiac TF and microRNA).

Figure 2

(A) Expression of ACTN2 and TNNT2 or (B) Expression of TNNT2 and Ki67 in HDF transdifferentiated for 2 weeks using induced expression of GATA4, TBX5, MEF2C, MYOCD, NKX2-5 and transfection with hsa-miR-1 and hsa-miR-133a. (Controls: M2rtTA only, microRNA only, cardiac TF only). (C) ACTN2. Panels on the right show varying degrees of cytoskeletal organization of ACTN2. (D) TNNT2. Panels on the right show varying degrees of cytoskeletal organization of TNNT2. (E) ACTN2 and GJA1. (F) TNNT2 and Ki67 expression in iCM. (G) VIM and MYH6/7. (H) TAGLN. (I) SMA. (J) MYH11. (K) ACTN2 expression in iCM 4 weeks following initiation of transdifferentiation. Panels on the right show varying degrees of cytoskeletal organization of ACTN2. (L) TNNT2 expression in iCM 4 weeks following initiation of transdifferentiation. Panels on the right show varying degrees of cytoskeletal organization of TNNT2.